News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
Partners

Teresa Marcarulla, MD

Articles by Teresa Marcarulla, MD

Expert Discusses Olaparib for BRCA+ Pancreatic Cancer

ByTeresa Marcarulla, MD

February 3rd 2020

The FDA's recent approval of olaparib for BRCA-positive pancreatic cancer is improving outcomes for many patients.

Latest Updated Articles

Expert Discusses Olaparib for BRCA+ Pancreatic Cancer
Published: February 3rd 2020 | Updated:

© 2025 MJH Life Sciences^®

All rights reserved.